Allogeneic mesenchymal stem cells as induction therapy are safe and feasible in renal allografts: pilot results of a multicenter randomized controlled trial

BACKGROUND: Kidneys from deceased donors are being used to meet the growing need for grafts. However, delayed graft function (DGF) and acute rejection incidences are high, leading to adverse effects on graft outcomes. Optimal induction intervention should include both renal structure injury repair a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Transl Med
Main Authors: Sun, Qipeng, Huang, Zhengyu, Han, Fei, Zhao, Ming, Cao, Ronghua, Zhao, Daqiang, Hong, Liangqing, Na, Ning, Li, Heng, Miao, Bin, Hu, Jianmin, Meng, Fanhang, Peng, Yanwen, Sun, Qiquan
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5842532/
https://ncbi.nlm.nih.gov/pubmed/29514693
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-018-1422-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados